Albuterol Nebulizer Dosing for COPD Exacerbation Treatment in Adults

Standard Dosing Protocol

The American Thoracic Society recommends an initial treatment of 2.5-5 mg albuterol via nebulizer every 20 minutes for up to 3 doses, with a maintenance treatment of 2.5-10 mg every 1-4 hours as needed 1, 2
For severe exacerbations, the American College of Chest Physicians suggests considering continuous nebulization at 10-15 mg/hour 2
The standard duration of treatment is 24-48 hours or until clinical improvement is observed, as recommended by the British Thoracic Society 3

For mild exacerbations, the European Respiratory Society recommends considering using a hand-held inhaler with 200-400 μg albuterol instead of a nebulizer, or using 2.5 mg albuterol via nebulizer 3
For moderate to severe exacerbations, the American Academy of Allergy, Asthma, and Immunology recommends using 2.5-5 mg albuterol via nebulizer every 20 minutes for 3 doses, then adjusting to 2.5-10 mg every 1-4 hours based on response 1, 2

The Global Initiative for Chronic Obstructive Lung Disease recommends combining albuterol (2.5-10 mg) with ipratropium bromide (250-500 μg) in the same nebulizer for more severe exacerbations, especially if the patient has had a poor response to either medication alone 3, 6, 7

The American Association for Respiratory Care recommends diluting aerosols to a minimum of 3 mL at a gas flow of 6-8 L/min for optimal delivery, and using large volume nebulizers for continuous administration 1, 2
In patients with carbon dioxide retention and acidosis, the nebulizer should be driven by air, not oxygen, as recommended by the European Respiratory Society 3
Before discharge, the American College of Chest Physicians suggests transitioning patients from nebulizer to hand-held inhaler treatment and observing for 24-48 hours 3

The American Thoracic Society recommends monitoring heart rate, respiratory rate, and oxygen saturation during treatment, and watching for side effects including tachycardia, skeletal muscle tremor, hypokalemia, and hyperglycemia 5